Aurinia Pharmaceuticals Inc.

AUPH·NASDAQ·$15.19Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/30/26 10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/04/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report08/19/26 8-KCurrent report08/06/26 8-KCurrent report06/04/26 8-KCurrent report05/11/26

Prospectuses and Registrations

S-8Registration of securities for employees05/16/25 S-8Registration of securities for employees05/26/23 S-3ASRAutomatic shelf registration11/19/21 S-8Registration of securities for employees06/25/21 S-8Registration of securities for employees02/24/21

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/30/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/17/25 DEFA14AAdditional proxy materials06/04/24

Ownership

Form 4Insider transaction09/11/26 SC 13D/ABeneficial ownership (amended)08/26/26 Form 4Insider transaction08/25/26 144Proposed sale of securities08/21/26 Form 4Insider transaction06/08/26

Other

SC TO-T/ASC TO-T/A05/11/26 SC TO-TThird party tender offer04/13/26 ARSAnnual report to shareholders05/03/24 SUPPLSUPPL07/23/20 SUPPLSUPPL07/22/20